Report of the Toronto and Ottawa Supervised Consumption Assessment Study. April 11, 2012



Similar documents
COMMUNITY SUPPORT FOR A SUPERVISED CONSUMPTION SITE IN OTTAWA

Introduction to Substance Abuse Issues in Canada: Pathways, Health Implications and Interventions

GROUND UP. Insite was specifically designed to be accessible to

European report on drug consumption rooms Executive summary

Getting help for a drug problem A guide to treatment

The Scientific Evaluation of Vancouver s Supervised Injection Site: The Evidence and Future Directions

Injection Drug Use, HIV and HCV Infection in Ontario: The Evidence 1992 to 2004

drug treatment in england: the road to recovery

Drug Situation in Vancouver UHRI. Report prepared by the Urban Health Research Initiative of the British Columbia Centre for Excellence in HIV/AIDS

Specialist Alcohol & Drug Services in Lanarkshire

Joint Committee on Health and Children

Feasibility Study on Supervised Drug Consumption Options in the City of Victoria

Analysis of survey data on the implementation of NICE PH18 guidance relating to needle and syringe provision in England

Part 5: Harm Reduction

OHRDP Communication and Information Toolkit for Needle Exchange Programs (NEPs)

-HHS Secretary Donna Shalala, 1998

REVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS

Treatment System 101

Queensland Corrective Services Drug and Alcohol Policy

1. Youth Drug Use More than 40% of Maryland high school seniors used an illicit drug in the past year.

Alcohol and drugs prevention, treatment and recovery: why invest?

Heroin and Crack Injection: Providing integrated responses and interventions for combination drug injectors

Testimony of The New York City Department of Health and Mental Hygiene. before the

DRUG & ALCOHOL POLICY

Vancouver Police Department Drug Policy

Heroin & injecting rooms

Protecting and improving the nation s health. Drug treatment in England

Dave Burrows Director

STOP TELLING US NOT TO SHARE Participatory project design

The 2002 Report Card

Best Practices and Barriers: An Update for Ontario Needle Exchange Programs

Development of the guidelines on the pharmacotherapy of addiction case study Croatia

UNODC World Drug Report 2016:

HOSC Report Integrated community drugs and alcohol service retendering options beyond April 2016

Evidence based Prevention & Treatment Options for Emerging Heroin Use in a Public Health Framework

THE DATA FOR ADULT DRUG TREATMENT LINCOLNSHIRE LINCOLNSHIRE E08B 32

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE. Psychosocial interventions in drug misuse

Community Based Treatment and Care for Drug Use and Dependence

Why invest? How drug treatment and recovery services work for individuals, communities and society

FALLING DRUG USE: THE IMPACT OF TREATMENT

Drug Abuse Trends in the Seattle/King County Area: 2013

Distributing safer crack use kits in Canada

A handbook for people who have injected drugs

Drug and Alcohol Agency Action Plan

Brief to the Toronto Board of Health regarding Supervised Injection Services in Toronto

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances

Case Study: Population and Public Health Program of the BC Provincial Health Services Authority i

Intake Consultation and Assessment Before Detox. What Happens During Drug Detox?

Details of need and our response can be found in the DAAT Treatment Plan which is available at

Research Note RN 00/91 1 November 2000 DRUG COURTS

Key Questions to Consider when Seeking Substance Abuse Treatment

Guidelines on harm reduction: experience from Villa Maraini Foundation/Italian Red Cross Fabio V. Patruno, Italian Red Cross

Joanne Lush, AIDS Bureau, Ministry of Health & Long-Term Care Maria Hatzipantelis, Ontario HIV Treatment Network

CURRICULUM TYPE: Block rotations with optional horizontal/ longitudinal curriculum in second year

Drug overdose: Prevention and response. Guidance for helplines

Adult drug treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities

Module 6 Alcoholism, Drug Abuse and Corruption

Evaluating OST programmes MMT and drug treatment in the Maldives

QUESTIONNAIRE FOR INTRAVENOUS DRUG USERS

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW

Overview of Chemical Addictions Treatment. Psychology 470. Background

Reshaping Drug and Alcohol Treatment in Westminster. Public Consultation

Family Services Of Greater Vancouver. Serving a High Needs Population in a Harm Reduction model. Jennifer Hanrahan Senior Manager of Youth Services

The Government's Drug Strategy

drug dependence treatment and care

UTAH DIVISION OF SUBSTANCE ABUSE AND MENTAL HEALTH SUBSTANCE USE DISORDER SERVICES MONITORING CHECKLIST (FY 2014) GENERAL PROGRAM REQUIREMENTS

Alcohol, Drugs & the Law.

CHAPTER Section 3 of P.L.2013, c.46 (C.24:6J-3) is amended to read as follows:

Wairarapa Wellness. A brief overview of mental health and addiction services in Wairarapa.

The story of drug treatment

Running head: PICOT PAPER 1. recidivism compared to no group therapy? Lara Hrynko. University of San Francisco

Arrest/Interview Rights *

THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW

Approaches to Alcohol and Drugs in Scotland: a Question of Architecture

THE ROLE OF EMERGENCY HOSTELS AND NIGHT SHELTERS IN SUPPORTING HOMELESS DRUG USERS: KEY FINDINGS

Patient Information Sheet

Extended brief interventions: up to 12 sessions of one to one support and access to group work

Drug Abuse Trends in the Seattle-King County Area: 2014

LEGISLATIVE ASSEMBLY OF THE NORTHERN TERRITORY 12th Assembly Ice Select Committee

Concurrent Session A: HIV/AIDS The Role of Criminal Law in Public Health

The Recovery Pathway Service forms a key component of the Sunderland Integrated Substance Misuse Service, as illustrated below:

At a glance: Accreditation principles and standards

Hepatitis Services in Substance Abuse Treatment Settings

Substance Misuse. See the Data Factsheets for more data and analysis:

Healthy People First: Opportunities and Risks in Health System Transformation in Ontario

Testimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition

Questions to ask before going to rehab by Rehab-Programs.org 2011

Reducing Drug Use, Reducing Reoffending Are programmes for problem drug-using offenders in the UK supported by the evidence?

Heroin Addiction.. Reaching Out!

Final Outcomes Action Steps/ Recommendations Limitations of Evaluation Conclusion Sources and Acknowledgements...

Our History Ottawa Inner City Health Inc.

The role of alcohol and drug rehabilitation in custodial settings. Amanda Street Sector Capacity Building Project Officer

Treatment Programs The Westover Model of Care

A LONG-TERM STUDY OF THE OUTCOMES OF DRUG USERS LEAVING TREATMENT SEPTEMBER 2010

Release of the revised curriculum for Health and Physical Education, Grades 1 to 12

SNAP: Telling Our Stories, Heroin Assisted- Treatment and Advocacy

Substance Abuse: A Public Health Problem Requiring Appropriate Intervention

HIV/AIDS policy. Introduction

Dr. Bayla Schecter, Addictions Specialist Helen Brown, RN Intake Nurse Louise Hill, MSW Addiction Outpatient Treatment (Quadra Clinic) Coordinator

Briefing Note: Hepatitis B & Hepatitis C. Summary:

Transcription:

Report of the Toronto and Ottawa Supervised Consumption Assessment Study April 11, 2012

www.toscastudy.ca Bayoumi AM and Strike C (co-principal investigators), Jairam J, Watson T, Enns E, Kolla G, Lee A, Shepherd S, Hopkins S, Millson M, Leonard L, Zaric G, Luce J, Degani N, Fischer B, Glazier R, O Campo P, Smith C, Penn R, Brandeau M. Report of the Toronto and Ottawa Supervised Consumption Assessment Study. Toronto, Ontario: St. Michael s Hospital and the Dalla Lana School of Public Health, University of Toronto. 2012

Supervised Consumption Facility A legally sanctioned health facility that offers a hygienic environment where people can use illicit drugs under the supervision of trained staff Injecting, smoking, or both 90+ facilities internationally, including Vancouver

Toronto and Ottawa 2005 Toronto Drug Strategy: Needs assessment and feasibility study for supervised consumption sites Subsequently, Toronto and Ottawa Supervised Consumption Assessment Study (TOSCA) Independent project Included Ottawa, which has the highest rate of new HIV infections among people who inject drugs in Ontario

Research Methods Focus groups & interviews with multiple stakeholders Public opinion survey Geographic analyses Analysis of administrative health data and survey Mathematical modelling Cost-effectiveness analyses Most comprehensive assessment of potential supervised consumption sites ever undertaken www.toscastudy.ca

Recommendation 1: Both Toronto and Ottawa would benefit from implementation of supervised injection facilities

Recommendation 1 Both Toronto and Ottawa have sizable numbers of people who use drugs Sharing of drug use equipment and public drug use is common We project that Toronto would benefit from implementation of 3 supervised injection facilities; Ottawa would benefit from implementation of 2 supervised injection facilities.

Recommendation 1 Projections based on considerations of The number of people who use drugs in each city Their geographic location The projected use of supervised injection facilities The demonstrated decrease in risky behaviours among clients of other supervised injection facilities The associated projected long-term costs and health benefits, including the prevention of HIV and hepatitis C infections

HCV Infections Averted Per Year Average Number of Hepatitis C Infections Averted Per Year 75 Average Number of Hepatitis C Infections Averted Per Year 75 50 50 25 25 0 0 1 2 3 4 5 Number of Facilities 0 0 1 2 3 4 5 Number of Facilities Toronto Ottawa Source: Modelling Study

HIV Infections Averted Per Year Average Number of HIV Infections Averted Per Year 20 Average Number of HIV Infections Averted Per Year 20 15 15 10 10 5 5 0 0 1 2 3 4 5 Number of Facilities 0 0 1 2 3 4 5 Number of Facilities Toronto Ottawa Source: Modelling Study

Recommendation 1 Multiple sites, rather than one Similar approach used to establish needle and syringe programs, methadone clinics Located close to where people use drugs People who use drugs do not want a single site that will focus opposition Community members preferred multiple facilities to minimize impact on local neighbourhoods

Recommendation 2: The optimal model for a supervised injection facility is a fixed facility that is integrated within an existing organization

Recommendation 2 Integration and close linkages with existing organizations offering a broad range of services Provide access to needed health and social services and referrals Do not duplicate what is already available Addresses concerns about establishing a relationship with people who use drugs as clients the visibility of a facility within a community privacy for clients community impact.

Recommendation 2 There are a number of services that might be considered for supervised injection sites or consumption rooms. How important are these to you? Very Important N % Nursing staff for medical care 305 (80) Food 261 (69) Toilets 254 (67) Drug counsellors 214 (56) Urgent detox beds 204 (54) Showers 202 (53) Social workers 193 (51) Source: Toronto I-Track

Recommendation 2 We do not recommend mandating attendance at ancillary services Mandatory attendance may discourage supervised injection

Recommendation 2 Mobile facilities might extend access for to hard-to-reach populations But we did not find a strong desire for a mobile service among people who use drugs in either city The evidence base for mobile sites is limited

Recommendation 3: A strong evaluation plan is an essential component of any implementation plan

Recommendation 3 A supervised injection facility must have a well-defined evaluation plan Plan must include clear objectives and specify the actions to be taken if the objectives are not achieved. Evaluation indicators should assess: The number of people who visit the facility How often they visit The proportion of people who use drugs who are clients of the facility The patterns of drug- and sex-related risk behaviours over time; Rates of HIV, hepatitis C, and hepatitis B infection over time Rates of fatal and non-fatal overdoses over time

Recommendation 3 I would support it under the conditions that it be brought in on a contract, with specific criteria around public safety and around success, under a variety of headings, that prevention of overdose, prevention of transmission of diseases, and bringing people into treatment, and if it didn t meet those, perhaps look at another strategy that would work better. (Toronto resident) Source: Focus Groups

Recommendation 3 The evaluation plan should also consider impacts at a community level, including changes in Public litter Visible public drug use The congregation of clients around a facility Drug-related crime and arrests Property values Local business viability.

Recommendation 4: A supervised injection facility should have clearly established rules

Recommendation 4 Based data from: Systematic review of scientific literature Survey data for Ottawa SIF study Stakeholder interviews & focus group discussions Among 47 SCFs worldwide, there is variation in the rules imposed within SCFs Rule focus: operating hours, time limits, registration, residency requirements, onsite behavioural expectations, drugs consumed

Rules reported by SCFs Registration at first visit Time limit Residency restriction Minimum age rule Non-first time injector rule Attendance tracking at subsequent visits Restricted areas of injecting on body rule Intoxicated indivduals allowed to inject Assisted injecting by other clients Expulsion for breaking rules Sharing drugs with other clients onsite Restrictions on drugs allowed Maximum number of injections per visit rule Dealing drugs onsite 0 20 40 60 80 100 Percent Source: Systematic Literature Review Allowed or Enforced Not Allowed or Enforced Not Reported

Recommendation 4 Stakeholders cautioned about the need for: Rules that balance needs of clients & community Rules that ensure safety of clients and staff You have to instil that there has to be respect, not only to the staff and from staff, but also between participants. There is just no other way to operate. (Toronto healthcare provider) Rules - not impede the potential for a SIF to meet objectives & improve client health E.g., Identification requirements

Recommendation 4 Stakeholders typically focused on rules about: Time limits to ensure access for clients You know, some people may smoke a piece and they want to tell you their life story Do your drugs and get out and make room for the next guy. (Ottawa person who uses drugs) Behavioural expectations for safety and comfort But in there, you re there to do drugs, you re not there to deal, you re not there to make friends, you re not there to exchange pieces, you re there to do your drugs. (Ottawa person who uses drugs) Voluntary versus mandatory counselling Nobody wants a counsellor standing over you. Saying, This is what you should be doing. But it [counselling] should be available if people want it. (Toronto people who use drugs)

Recommendation 4 Stakeholders typically focused on rules about: Anonymity and privacy to encourage attendance You come in anonymously, you leave anonymously. (Toronto person who uses drugs) Age restrictions very mixed opinions Maybe age sixteen. You can quit school at sixteen, you can drive a car at sixteen. (Toronto person who uses drugs) I was on the street when I was fourteen. (Ottawa person who uses drugs) Assisted injection very mixed opinions Consider local context when deciding rules

Recommendation 5: Insufficient evidence to support a recommendation to implement a supervised smoking facility

Recommendation 5 Based on data from: I-track and survey data for Ottawa SIF study Stakeholder interviews & focus group discussions Limited scientific evidence available about the impact of SSF on risk behaviours and longer term outcomes of disease transmission Intention to use SSFs - 58% to 84%

Use of a supervised smoking facility in Toronto Would you use a supervised room for safer crack smoking? N (%) All (n=450) 288 (64) People who inject drugs (n=238) 139 (58) People who smoke crack cocaine (n=212) 149 (70) Men (n=316) 201 (64) Women (n=131) 85 (65) Source: 2006 Toronto I-Track Survey The analysis by gender excludes transgendered people. Use of a supervised smoking facility in Ottawa Would you use a supervised room for safer crack smoking? N (%) All (n=245) 154 (63) Men (n=177) 112 (63) Women (n=68) 42 (62) Source: Leonard, DeRubeis and Strike, 2008

Recommendation 5 25% of people who smoke crack said that they would not use an SCS Stakeholder data about intended frequency of utilization sheds some doubt on frequency a SSF would be used Really, I can run behind a building and do a quick puff (Toronto person who uses drugs) Low frequency use of a SSF may limit potential to change behaviours & influence health outcomes Best service model for people who smoke drugs like crack is unclear

Recommendation 5 Many injectors also smoke drugs like crack Many people who injected drugs (74%) would use a facility with injecting & smoking rooms Offering supervised smoking within a SIF injecting facility may increase utilization and potential impact on behaviours and outcomes. That, I think, would be the best. Same site, but in separate rooms. (Ottawa person who uses drugs) Investigation of the design and impact of a mixed service model is warranted.

Recommendation 6: Process to establish SIF should be part of a comprehensive drug strategy

Recommendation 6 Based data from: Stakeholder interviews & focus group discussions Public opinion data Strategy to address the health & wellbeing of the individual & broader community Four pillar approach prevention, treatment, enforcement and harm reduction And I think the community would be more receptive, from our drug strategy work, as long as harm reduction was connected to treatment options and housing and all of those other things. (Ottawa advisory group participant)

Recommendation 6: Comprehensive drug strategy Address stakeholder concerns about other underlying health and social problems experienced by people who use drugs. Work collaboratively & not duplicate existing resources Do not divert resources from effective programs I wouldn t want to see like sort of a one-shot deal or somebody trying to do it all on their own. I d like to see a collaborative effort, and it would include maybe tackling some of those more difficult issues. (Toronto city employee)

Recommendation 6 Percentage 100% 80% 60% 40% 22 32 31 31 16 14 28 31 11 10 11 26 31 38 15 33 20% 45 38 56 55 58 51 64 52 Some always opposed Over 50% - Toronto & Ottawa - support SIFs Increased support 03-09 0% Toronto Ottawa Toronto Ottawa Toronto Ottawa Toronto Ottawa Encourage safe drug use Reduce overdose death or infectious disease Increase contact with health and social workers Strongly Agree Somewhat Agree or Disagree Strongly Disagree Reduce neighbourhood problems related to injection drug use

Recommendation 6 Consult other cities but implement for Ottawa & Toronto contexts What do they have in Vancouver and what works and doesn t work are the things that I would be wondering myself. I don t know how to run a safe injection site I m not a public health person. So before I would want to give advice on conditions that I think would be good for Ottawa, I would like to know what others are doing so I could see, would that work in our community or not? (Ottawa resident)

Recommendation 6 Clearly articulated SIF goals and objectives to assess role and fit within larger drug strategy Transparent implementation plans Mechanisms for stakeholder input I think it s important to get people involved. Just like a lot of people are ignorant, they don t know what s going on. Especially people who sort of went through a change like we ve have. We ve been through a lot in this community. And I think community input s important. I think it would get rid of a lot of the fear and anger. And that s one thing our community lacks, is consultation. (Toronto resident) Location is important for all stakeholder who want to be consulted

Acknowledgements Study participants for their willingness to share their opinions and data. Funding: Ontario HIV Treatment Network & CIHR Institutes of Health Research. Support: Centre for Research on Inner City Health at St. Michael¹s Hospital, Dalla Lana School of Public Health at the University of Toronto, the Institute for Clinical Evaluative Sciences, and the Centre for Addiction and Mental Health. The Centre for Research on Inner City Health is part of the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael¹s Hospital. The Center for Research on Inner City Health is supported in part by a grant from the Ontario Ministry of Health and Long-Term Care (OMHLTC). The Institute for Clinical Evaluative Sciences and the Centre for Addiction and Mental Health are funded by an annual grants from the OMLTC. The views expressed in this report are the views of the authors and do not necessarily reflect the views of the Ontario Ministry of Health and Long-Term Care, the funding agencies, or supporting organizations. No endorsement by St. Michael¹s Hospital, the University of Toronto, the Institute for Clinical Evaluative Sciences or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred.